To conclude, until new and better APO biomarkers are developed, a model including ethnicity, smoking status, pre-gestational hypertension, and corticosteroids treatment at the beginning of pregnancy could efficiently stratify pregnant women with the most common autoimmune diseases according to their risk for subsequently presenting an adverse pregnancy outcome. This evidence concerns the gene AOPEP and preeclampsia.